Literature DB >> 11171070

Expression and characterization of recombinant human alpha-3/4-fucosyltransferase III from Spodoptera frugiperda (Sf9) and Trichoplusia ni (Tn) cells using the baculovirus expression system.

V A Morais1, J Serpa, A S Palma, T Costa, L Maranga, J Costa.   

Abstract

The human alpha-3/4-fucosyltransferase III (Fuc-TIII) participates in the synthesis of Lewis determinants. The enzyme from human sources is scarce and heterogeneous. In this paper we describe the expression of a secreted form of Fuc-TIII (SFT3) in two insect cell lines, Spodoptera frugiperda (Sf9) and Trichoplusia ni (Tn), using the baculovirus expression system. The Sf9 cells secreted approx. 0.4 unit/l (1 mg/l) of the enzyme. The Tn cells secreted approx. 3-fold this amount. A large proportion of active protein was accumulated in the two cell lines (50 and 75% respectively for Sf9 and Tn cells, on the fourth day after infection) indicating a possible limitation not only of the folding machinery, but also a saturation of the secretory pathway. SFT3 was purified by cation-exchange chromatography followed by affinity chromatography. The enzyme from the Tn cell line had a lower global charge, possibly due to post-translational modifications, such as phosphorylation or sulphation. The two glycosylation sites from SFT3 were occupied. SFT3 secreted by Sf9 cells was completely deglycosylated by peptide-N-glycanase F, whereas 50% of SFT3 secreted by Tn cells was resistant to deglycosylation by this enzyme. The apparent kinetic parameters determined with the type I acceptor were k(cat)=0.4 s(-1) and K(m)=0.87 mM for the SFT3 secreted by Tn cells, and k(cat)=0.09 s(-1) and K(m)=0.76 mM for the SFT3 secreted by Sf9 cells, indicating that the enzymes had substrate affinities within the same order of magnitude as their mammalian counterpart. Furthermore, SFT3 secreted by either cell type showed a clear preference for type 1 carbohydrate acceptors, similarly to human Fuc-TIII.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11171070      PMCID: PMC1221619          DOI: 10.1042/0264-6021:3530719

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  26 in total

1.  Large-scale production and purification of functional recombinant bovine rhodopsin with the use of the baculovirus expression system.

Authors:  C H Klaassen; P H Bovee-Geurts; G L Decaluwé; W J DeGrip
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

2.  Expression of functional soluble forms of human beta-1, 4-galactosyltransferase I, alpha-2,6-sialyltransferase, and alpha-1, 3-fucosyltransferase VI in the methylotrophic yeast Pichia pastoris.

Authors:  M Malissard; S Zeng; E G Berger
Journal:  Biochem Biophys Res Commun       Date:  2000-01-07       Impact factor: 3.575

3.  Recombinant human aggrecan G1-G2 exhibits native binding properties and substrate specificity for matrix metalloproteinases and aggrecanase.

Authors:  F A Mercuri; K J Doege; E C Arner; M A Pratta; K Last; A J Fosang
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Expression of a recombinant baculovirus for vitronectin in insect cells: purification, characterization of post-translational modifications and functional studies of the recombinant protein.

Authors:  Y Zhao; D C Sane
Journal:  Arch Biochem Biophys       Date:  1993-08-01       Impact factor: 4.013

6.  Purification and properties of the alpha-3/4-L-fucosyltransferase released into the culture medium during the growth of the human A431 epidermoid carcinoma cell line.

Authors:  P H Johnson; A S Donald; W M Watkins
Journal:  Glycoconj J       Date:  1993-04       Impact factor: 2.916

7.  Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins.

Authors:  Y Matsuura; R D Possee; H A Overton; D H Bishop
Journal:  J Gen Virol       Date:  1987-05       Impact factor: 3.891

8.  Reassessment of the acceptor specificity and general properties of the Lewis blood-group gene associated alpha-3/4-fucosyltransferase purified from human milk.

Authors:  P H Johnson; A S Donald; J Feeney; W M Watkins
Journal:  Glycoconj J       Date:  1992-10       Impact factor: 2.916

9.  Purification of the Lewis blood-group gene associated alpha-3/4-fucosyltransferase from human milk: an enzyme transferring fucose primarily to type 1 and lactose-based oligosaccharide chains.

Authors:  P H Johnson; W M Watkins
Journal:  Glycoconj J       Date:  1992-10       Impact factor: 2.916

10.  A cloned human cDNA determines expression of a mouse stage-specific embryonic antigen and the Lewis blood group alpha(1,3/1,4)fucosyltransferase.

Authors:  J F Kukowska-Latallo; R D Larsen; R P Nair; J B Lowe
Journal:  Genes Dev       Date:  1990-08       Impact factor: 11.361

View more
  2 in total

1.  Localization, purification and specificity of the full-length membrane-bound form of human recombinant alpha 1,3/4-fucosyltransferase from BHK-21B cells.

Authors:  V L Sousa; M T Costa; A S Palma; F Enguita; J Costa
Journal:  Biochem J       Date:  2001-08-01       Impact factor: 3.857

2.  Improving the baculovirus expression vector system with vankyrin-enhanced technology.

Authors:  Kendra H Steele; Barbara J Stone; Kathleen M Franklin; Angelika Fath-Goodin; Xiufeng Zhang; Haobo Jiang; Bruce A Webb; Christoph Geisler
Journal:  Biotechnol Prog       Date:  2017-07-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.